| P50 | author | David H Hwang | Q88563892 |
| | Lynette M Sholl | Q89916147 |
| P2860 | cites work | MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression | Q27853312 |
| | Comparison of glass slides and various digital-slide modalities for cytopathology screening and interpretation. | Q30101026 |
| | Somatic mutations lead to an oncogenic deletion of met in lung cancer | Q40333112 |
| | Next-generation sequencing of cytologic preparations: An analysis of quality metrics. | Q48094842 |
| | Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, | Q52579847 |
| | Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies. | Q52927134 |
| | Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer | Q57476349 |
| | Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR–Based Targeted Next-Generation Sequencing | Q59195919 |
| | Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens | Q84763510 |
| | BRAF Adds an Additional Piece of the Puzzle to Precision Oncology-Based Treatment Strategies in Lung Cancer | Q88341138 |
| | Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples | Q89210665 |
| | DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer | Q91031006 |
| | Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions | Q91044747 |
| | High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden | Q91555914 |
| | Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA | Q91998079 |
| | Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic Isoforms | Q92845391 |
| | The International Association for the Study of Lung Cancer (IASLC) Global Survey on Molecular Testing in Lung Cancer | Q95643804 |
| P921 | main subject | biomarker | Q864574 |
| P577 | publication date | 2020-10-29 | |
| P1433 | published in | Cancer Cytopathology | Q13452937 |
| P1476 | title | Expanding the utility of cytology preparations in cancer biomarker testing | |